SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-07-261491
Filing Date
2007-12-07
Accepted
2007-12-07 17:14:15
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 ds3.htm S-3 209192
2 OPINION OF FISHER THURBER LLP dex51.htm EX-5.1 24855
3 RATIO OF EARNINGS TO FIX CHARGES dex121.htm EX-12.1 12430
4 CONSENT OF MARCUM & KLIEGMAN LLP dex231.htm EX-23.1 1680
5 GRAPHIC g49615g60r98.jpg GRAPHIC 26151
  Complete submission text file 0001193125-07-261491.txt   286007
Mailing Address 3611 VALLEY CENTRE DRIVE, SUITE 525 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE, SUITE 525 SAN DIEGO CA 92130 (858) 436-1000
Cardium Therapeutics, Inc. (Filer) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-147947 | Film No.: 071293378
SIC: 2836 Biological Products, (No Diagnostic Substances)